Health Management

The new global DNA registry could help enable more precise treatments and identify who’s at risk for certain health problems.

A new study shows efforts to reduce prescription opioid use in adults has not curtailed the incidence of pediatric opioid ingestions. Find out why.

When caring for cancer patients, improving care coordination in these two areas is key-and it can help reduce healthcare costs.

Unfortunately, the issue for many vets who experience trauma is that the mental health services they need are too far away from home. Here’s one solution.

A new report highlights physical, social, and economic challenges of migraine.

Rideshare giants Uber and Lyft partner with providers to help get patients to their medical appointments, as well as improve the overall patient experience. Here’s five takeaways from industry watchers.

The Cigna-Express Scripts deal may signal a move to more vertical and horizontal healthcare deals. Here’s what else it means.

HHS Secretary Alex M. Azar II lays out top four HHS initiatives and calls on payers and providers to align.

Biologics, early treatment, and lifestyle choices take the spotlight in rheumatoid arthritis advances.

A lack of national standards and less than optimal oversight of many inpatient, opioid addiction rehabilitation programs is raising questions about the level of services, personnel, and quality of care many patients are receiving.

Switzerland-based pharma company Roche’s $1.9 billion purchase of tech company Flatiron Health signifies Big Pharma’s need for data.

Successful CAR T-cell therapy reimbursement begins with careful payer-provider collaboration and taking these two approaches.

A study from Human Rights Watch has eye-opening findings about antipsychotic drug prescribing in U.S. nursing homes.

We asked the Managed Healthcare Executive board to share their favorite app-for work or for play. Here’s what they said.

Retail drug chain giant Walgreens made a takeover approach to drug distributor AmerisourceBergen. Here’s what industry watchers want you to know about it.

The healthcare landscape is transforming. Here are six considerations to help your talent during restructuring, downsizing, and other transitions.

Here are three strategies to navigate toward next-generation care management and increase member engagement in the process

Understanding the key barriers to biosimilar adoption in the U.S. is the first step managed care executives can take to overcome these obstacles, according to a Trinity Parners report.

Treatment failures can result in a spectrum of problems for patients with hemophilia. Here’s some guidance on choosing the right therapy.

Study reveals growing acceptance of value-based payments among family physicians, but barriers still exist.

The benefits and drawbacks of predictive modeling in end-of-life care decision making.

Shift represents growing understanding of value of genetic testing for cancers. Find out who is receiving the test and why.

Corporate giants Amazon, Berkshire Hathaway, and JPMorgan Chase, partner to shake things up in U.S. employee healthcare.

Two new studies reveal that cost-restraints can keep patients from accessing life-preserving cancer drugs.

In partnership with the several big-name cancer centers, one company has commenced clinical trials. Find out how this cancer vaccine would work.

Reducing readmissions for chronic obstructive pulmonary disease (COPD) is an ongoing challenge for healthcare systems. Here’s how one is successful.

From State-led programs to innovative pharmacist-hospital partnerships, these programs are fighting to quell the epidemic.

How are generic prices changing, how will biosimilars impact costs, and what changes out of Washington should healthcare executives watch? Economics guru Joe Fuhr weighs in.

The high cost of specialty drugs continues to plague the healthcare industry. Here’s why.

Many providers are overlooking important steps that can help guide proper COPD treatment and therefore, reduce admissions and readmissions.